Inverse psoriasis in patient treated with atezolizumab
Int J Dermatol
.
2020 Sep;59(9):e331-e332.
doi: 10.1111/ijd.14876.
Epub 2020 Apr 28.
Authors
Paola Corneli
1
,
Nicola di Meo
1
,
Serena Fagotti
1
,
Claudio Conforti
1
,
Eleonora Farinazzo
1
,
Alberto Zacchi
2
,
Chiara Retrosi
1
,
Roberta Vezzoni
1
,
Maria A Pizzichetta
3
,
Iris Zalaudek
1
Affiliations
1
Department of Dermatology, Maggiore Hospital of Trieste, University of Trieste, Trieste, Italy.
2
Department of Pathological Anatomy, Cattinara Hospital of Trieste, Trieste, Italy.
3
Department of Medical Oncology-Preventive Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
PMID:
32346858
DOI:
10.1111/ijd.14876
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / adverse effects
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Psoriasis* / drug therapy
Substances
Antibodies, Monoclonal, Humanized
atezolizumab